A study reveals economic inequality is a key predictor of pandemic response effectiveness, urging nations to prioritize ...

Among healthcare providers, 89% (n=16/18) reported a positive overall opinion of administering CAB LA for PrEP in their practice. Prescribers cited benefits of regular injection visits, including ...

Disruptions to funding and new policies aimed at aligning foreign aid programs with the Trump administration’s agenda have ...

ViiV Healthcare’s Dovato has been approved for use in the US and EU since 2019, but its sales remain overshadowed by Gilead’s Biktarvy.

Around 77,000 fewer children worldwide received HIV treatment supported by the U.S. since October 2025 than in the previous ...

Dovato is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg in the EU, and weighing at least ...

South Africa has more than half of all Africans using the world's newest HIV prevention injection. But the real story lies ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced today that it will make three ...

People with hearing loss who received a hearing-aid prescription faced a 5.0 percent chance of developing dementia over seven ...

A new antiretroviral combination pill that is taken only once a week appears to work as well as daily pills at treating HIV. This is according to interim study findings to be presented next week at ...

A new research study examining the scale of disruptions to HIV programmes caused by funding cuts from the United States’ ...

For more than two decades, scientific innovation and international financing have worked together to transform HIV from a ...